JESSICA SCHNEIDER: Open Payments
NPI 1487027025 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 14 payments from 8 companies in 2025. Trend: 2023 $571 · 2024 $540 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $65 |
| Organon LLC | 2 | $39 |
| Hologic Sales and Service, LLC | 2 | $38 |
| Evofem Biosciences, Inc. | 2 | $33 |
| Sage Therapeutics, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $10 |
Products named: Veozah, NEXPLANON, FLUENT FLUID MANAGEMENT SYSTEM, Phexxi, ZURZUVAE, LILETTA, MYFEMBREE, Heplisav-B.
Industry payments across MO — which companies pay providers there.
